We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
For investors looking for momentum, Vanguard Growth ETF (VUG - Free Report) is probably a suitable pick. The fund just hit a 52-week high and is up 43.1% from its 52-week low price of $218.28/share.
Let’s take a look at the fund and its near-term outlook to gain an insight into where it might be headed:
VUG in Focus
The fund seeks to track the performance of the CRSP US Large Cap Growth Index. It has AUM of $86.74 billion and charges 4 basis points in annual fees.
Why the Move?
Wall Street has been loudly cheering the third-quarter earnings season that has begun on a positive note. Going on, there have been certain upbeat economic data releases that have raised investor optimism. The coronavirus vaccine rollout is gradually helping control the spread of the outbreak across the globe. Accordingly, the global demand and economic growth levels are on the path of recovery from the pandemic-led slump. Investors and vaccine makers like Moderna (MRNA) andJohnson & Johnson (JNJ) have reasons to cheer the latest update concerning the application of COVID-19 booster shots. Investors have rotated back into growth-oriented market areas in recent weeks on optimism surrounding the economic recovery. This is making funds like VUG an impressive investment option.
Image: Bigstock
Vanguard Growth ETF (VUG) Hits a 52-Week High
For investors looking for momentum, Vanguard Growth ETF (VUG - Free Report) is probably a suitable pick. The fund just hit a 52-week high and is up 43.1% from its 52-week low price of $218.28/share.
Let’s take a look at the fund and its near-term outlook to gain an insight into where it might be headed:
VUG in Focus
The fund seeks to track the performance of the CRSP US Large Cap Growth Index. It has AUM of $86.74 billion and charges 4 basis points in annual fees.
Why the Move?
Wall Street has been loudly cheering the third-quarter earnings season that has begun on a positive note. Going on, there have been certain upbeat economic data releases that have raised investor optimism. The coronavirus vaccine rollout is gradually helping control the spread of the outbreak across the globe. Accordingly, the global demand and economic growth levels are on the path of recovery from the pandemic-led slump. Investors and vaccine makers like Moderna (MRNA) andJohnson & Johnson (JNJ) have reasons to cheer the latest update concerning the application of COVID-19 booster shots. Investors have rotated back into growth-oriented market areas in recent weeks on optimism surrounding the economic recovery. This is making funds like VUG an impressive investment option.
More Gains Ahead?
It seems like the fund will remain strong, with a positive weighted alpha of 36.98, which gives cues of a further rally.